Yottar | $1,000,000 | (Aug 28, 2025)
Matiks | $3,100,000 | (Aug 28, 2025)
Sequifi | $6,700,000 | (Aug 28, 2025)
Certified by Founder
Lodge
LoQus23 Therapeutics Ltd
start up
United Kingdom
- Cambridge, Cambridgeshire
- 02/10/2024
- Series A
- $46,550,175
LoQus23 are discovering oral small molecule therapies targeting aberrant DNA mismatch repair to effectively treat Huntington’s and other triplet repeat diseases.
- Industry Biotechnology Research
- Website https://loqus23.com/
- LinkedIn https://www.linkedin.com/company/loqus23-therapeutics-ltd/
Bench IQ | $5,300,000 | (Aug 28, 2025)
Heave | $7,000,000 | (Aug 28, 2025)
InstaLILY AI | $25,000,000 | (Aug 28, 2025)
Vox AI | $8,738,305 | (Aug 28, 2025)
Artificial Societies | $5,350,000 | (Aug 28, 2025)
Central | $8,600,000 | (Aug 28, 2025)
Reframe Systems | $20,000,000 | (Aug 27, 2025)
Aurasell AI | $30,000,000 | (Aug 27, 2025)
Therna Biosciences | $10,000,000 | (Aug 27, 2025)